Suncoast Equity Management’s Telomir Pharmaceuticals TELO Stock Holding History

Suncoast Equity Management’s Portfolio TELO Stock Details TELO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.6K	Hold	51,194	–	–	0.01%	93
2025 Q4	$68.1K	Hold	51,194	–	–	0.01%	89
2025 Q3	$71.2K	Hold	51,194	–	–	0.01%	88
2025 Q2	$64K	Hold	51,194	–	–	0.01%	84
2025 Q1	$165K	Hold	51,194	–	–	0.02%	78
2024 Q4	$211K	Hold	51,194	–	–	0.02%	73
2024 Q3	$329K	Buy	51,194 +26,803	+110%	+$131K	0.04%	64
2024 Q2	$117K	Hold	24,391	–	–	0.01%	67
2024 Q1	$126K	Buy	+24,391	New	+$184K	0.01%	68

Other funds holding TELO

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WIA

World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Suncoast Equity Management's TELO Position: Q1 2026 in Review

Suncoast Equity Management held its Telomir Pharmaceuticals (TELO) position steady in Q1 2026 at 51,194 shares worth $66.6K. The position accounts for 0.01% of the portfolio, ranked #93.

Suncoast Equity Management first reported a position in TELO in Q1 2024 and has held it in 9 quarters since. The position peaked at $329K in Q3 2024. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

Suncoast Equity Management held 51,194 shares of Telomir Pharmaceuticals worth $66.6K as of Q1 2026.
Suncoast Equity Management left its Telomir Pharmaceuticals share count unchanged in Q1 2026.
Telomir Pharmaceuticals made up 0.01% of Suncoast Equity Management's portfolio in Q1 2026, its #93 holding.
Suncoast Equity Management first reported a position in Telomir Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Suncoast Equity Management's Telomir Pharmaceuticals position peaked at $329K in Q3 2024.
27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Suncoast Equity Management's 13F filing for Q1 2026, filed 8 May 2026.